Source: New York Post
Originally Published by: Hawley introduces bill to strip FDA approval from 'inherently dangerous' abortion pill Supreme Court temporarily blocks appeals court ruling on abortion pill, restores wider access to drug Top Republicans take abortion pill fight to Supreme Court, citing coercion and safety risks The chief executive of America’s oldest pro-life organization told Fox News Digital that President Donald Trump’s FDA nominee, Dr. Heidi Overton, could bring renewed scrutiny to mifepristone, the abortion drug at the center of an ongoing federal safety review. John Mize, CEO of Americans United for Life (AUL), said he has had five or six conversations with Overton, who is known for her pro-life views.
